Uninsured US patients pay up to $330 for Eli Lilly’s $25 insulin, Senator Warren says

By Patrick Wingrove (Reuters) – Americans without health insurance pay an average of $98 for Eli Lilly’s generic insulin despite the company’s May 1 pledge to cut its list price to $25 per vial, according to a survey of more than 300 U.S. pharmacies by U.S. Senator Elizabeth Warren’s office released on Thursday. Warren’s survey…

Read More

Coca-Cola to see less pain from looming WHO decision on aspartame – analysts

By Savyata Mishra (Reuters) – (This June 30 story has been officially corrected to drop the reference to aspartame being removed from PepsiCo products in 2020, in paragraph 9. A PepsiCo spokesperson corrected an earlier statement from an outside company spokesperson) Coca-Cola will only see a limited impact if the world health agency classifies the…

Read More

WHO’s cancer research agency to say aspartame sweetener a possible carcinogen -sources

By Jennifer Rigby and Richa Naidu LONDON (Reuters) – (This June 29 story has been corrected to drop the reference to aspartame being removed from PepsiCo products in 2020, in paragraph 25. A PepsiCo spokesperson corrected an earlier statement from an outside company spokesperson) One of the world’s most common artificial sweeteners is set to…

Read More

US FDA reviewing concerns over Logan Paul’s PRIME energy drink

(Reuters) – The U.S. Food and Drug Administration said on Wednesday it is reviewing concerns raised by Senate Majority Leader Chuck Schumer against a popular influencer-created energy drink. Schumer said earlier this month that PRIME, a beverage brand started last year by YouTube stars Logan Paul and KSI, should be investigated due to the high…

Read More

Factbox-Analysts guarded as AI-driven US stock rally faces earnings test

(Reuters) – Analysts are cautiously optimistic as second-quarter reporting season rolls out amid this year’s rally in U.S. stocks fueled by optimism over artificial intelligence (AI) and a resilient U.S. economy. Strategists expect profit at S&P 500 companies to have dropped 6.4% in the second quarter from a year earlier, according to Refinitiv data. Several…

Read More

How aspartame made the agenda of the WHO’s cancer research arm

By Jennifer Rigby LONDON (Reuters) – The imminent move to label aspartame as a possible carcinogen comes after years of advocacy from a leading consumer group in the United States and a handful of cancer scientists hoping to settle a decades-long debate over the sweetener’s safety.     Reuters reported last month that the cancer research arm…

Read More

AIDS can be ended by 2030 with investments in prevention and treatment, UN says

GENEVA (Reuters) – It is possible to end AIDS by 2030 if countries demonstrate the political will to invest in prevention and treatment and adopt non-discriminatory laws, the United Nations said on Thursday. In 2022, an estimated 39 million people around the world were living with HIV, according to UNAIDS, the United Nations AIDS program….

Read More

Florida judge allows re-enactment in Parkland school shooting case

By Rachel Nostrant (Reuters) – A Florida judge ruled on Wednesday that she will allow a re-enactment of the 2018 school shooting at Marjory Stoneman Douglas High School in Parkland, Florida, to be filmed as part of the civil suit against resource officer Scot Peterson for allegedly failing to protect students. The ruling means that…

Read More